Clinical Trials Logo

2?Elekta Precise 1343 Digital Control Electron Linear Accelerator clinical trials

View clinical trials related to 2?Elekta Precise 1343 Digital Control Electron Linear Accelerator.

Filter by:
  • None
  • Page 1

NCT ID: NCT01689558 Recruiting - Clinical trials for 2?Elekta Precise 1343 Digital Control Electron Linear Accelerator

Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

Start date: December 2011
Phase: Phase 2/Phase 3
Study type: Interventional

1) Observe and compare the curative effect of endostatin/recombined Endostatin in alliance with neoadjuvant chemotherapy and Concurrent chemo-radio therapy to treat the local advanced nasopharyngeal darcinoma; 2) Evaluate the security and tolerability in endostatin/recombined Endostatin in alliance with neoadjuvant chemotherapy and Concurrent chemo-radio therapy to treat the local advanced nasopharyngeal darcinoma.